AMPLEXA GENETICS A/S: Financial statements 2020
CVR: 29428441
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 12,423,888 and a net result of DKK 5,872,852 compared with DKK -1,500,826 the year before. That is an increase of 338.9% compared with the year before. Equity in the 2020 report amounted to DKK -24,536,833. The company had 7 employees in the financial year.
- Gross Profit
- DKK 12,423,888
- Profit/Loss
- DKK 5,872,852
- Equity
- DKK -24,536,833
- Total Assets
- DKK 12,290,976
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 12.4 mio. | 5.9 mio. | -24.5 mio. | 7 |
| 2019 | - | 2.8 mio. | -1.5 mio. | -30.4 mio. | 7 |
| 2018 | - | 907 t. | -3.7 mio. | -28.9 mio. | 7 |
| 2017 | - | 718 t. | -3 mio. | -25.2 mio. | 6 |
| 2016 | - | 440 t. | -2.7 mio. | -22.3 mio. | - |
Official annual report
How creditworthy is AMPLEXA GENETICS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
AMPLEXA GENETICS A/S has published its annual report for 2019. Gross profit came to DKK 2,830,722, and the net result was DKK -1,500,826.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The board consists of Magnus Herdalur (chair), Eydfinn Reydberg and Ulf Bech Christensen. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity in the 2025 report amounted to DKK -10,313,267.